Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs
Clinical trial NCT00016718 · COMPLETED
Trial details
- NCT number
- NCT00016718
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-08-01
- Primary completion
- 2009-01-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.